Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
for
Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
Location: Dallas TX, San Antonio TX, Indianapolis IN,
Sponsor: Hummingbird Bioscience
Sex: All
Age: 18+
Code: NCT06956690
Phase 1, Phase 2, Recruiting
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
An International Observational Study of Adults With Acute Infection
for
Infectious Disease
Location: Dallas TX, Houston TX, Kansas City KS, Omaha NE,
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT07069400
Recruiting
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
for
Hepatorenal Syndrome, Acute Kidney Injury
Location: Fort Worth TX, Nashville TN, Atlanta GA, Rochester MN,
Sponsor: River 2 Renal Corp.
Sex: All
Age: 18+
Code: NCT05875948
Phase 2, Recruiting
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
for
Low Grade Upper Tract Urothelial Carcinoma
Location: Dallas TX, Austin TX, Houston TX, St Louis MO,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT07265947
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
for
Alcohol-associated Hepatitis
Location: Dallas TX, Louisville KY, Indianapolis IN, Rochester MN,
Sponsor: Samer Gawrieh
Sex: All
Age: 18 - 70
Code: NCT07060638
Phase 2, Recruiting
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
for
Refractory Melanoma
Location: Dallas TX, Birmingham AL, Gilbert AZ, Scottsdale AZ,
Sponsor: Diakonos Oncology Corporation
Sex: All
Age: 18+
Code: NCT07288112
Phase 1, Phase 2, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
for
Metastatic Breast Cancer in the Liver
Location: Dallas TX, Columbus OH, Tampa FL, Cleveland OH,
Sponsor: Delcath Systems Inc.
Sex: All
Age: 18+
Code: NCT06875128
Phase 2, Recruiting
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
for
Anesthesia, Propofol Adverse Reaction,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Location: Dallas TX, Houston TX, St Louis MO, Birmingham AL,
Sponsor: Cook Research Incorporated
Sex: All
Age: 18+
Code: NCT04875429
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Dallas TX, St Louis MO, Birmingham AL, Indianapolis IN,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase 1, Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
for
Carcinoma, Renal Cell
Location: Dallas TX, Germantown TN, St Louis MO, Marietta GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07489495
Phase 3, Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
for
Small Cell Lung Cancer (SCLC ),
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Moonlight Bio, Inc
Sex: All
Age: 18+
Code: NCT07488923
Phase 1, Recruiting
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: Dallas TX, Pittsburgh PA, Duarte CA, Palo Alto CA,
Sponsor: RefleXion Medical
Sex: All
Age: 0+
Code: NCT05406167
Recruiting
Converting HR+ Breast Cancer Into an Individualized Vaccine
for
Breast Cancer
Location: Dallas TX, Houston TX, New York NY
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18 - 70+
Code: NCT03804944
Phase 2, Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
for
Ulcerative Colitis, Crohn Disease
Location: Dallas TX, Houston TX, Aurora CO, Chicago IL,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05230173
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Fort Worth TX, Shreveport LA, Austin TX, Houston TX,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase 3, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Nashville TN,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase 2, Recruiting
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study